dihydroxyphenylalanine has been researched along with Uterine Neoplasms in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M | 1 |
| Ueda, G | 1 |
| Yamasaki, M | 1 |
| Tanaka, Y | 1 |
| Hiramatsu, K | 1 |
| Sakumoto, T | 1 |
| Kurachi, K | 1 |
| Maeyama, K | 1 |
| Yamatodani, A | 1 |
1 other study available for dihydroxyphenylalanine and Uterine Neoplasms
| Article | Year |
|---|---|
Capacity for amine-precursor uptake and decarboxylation of argyrophil cell adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Animals; APUD Cells; Catecholamines; Decarboxylation; Dihydroxyphenylalanine; Female | 1982 |